Resultados da pesquisa - Kota Iwahori
- A mostrar 1 - 15 resultados de 15
-
1
-
2
Tetracyclines enhance antitumor T-cell immunity via the Zap70 signaling pathway Por Mari Tone, Kota Iwahori, Michinari Hirata, Azumi Ueyama, Akiyoshi Tani, Jun‐ichi Haruta, Yoshito Takeda, Yasushi Shintani, Atsushi Kumanogoh, Hisashi Wada
Publicado em 2024Artigo -
3
iTRAQ-based proteomic identification of leucine-rich -2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases Por Satoshi Serada, Minoru Fujimoto, Atsushi Ogata, Fumitaka Terabe, T Hirano, Hideki Iijima, Shinichiro Shinzaki, Teppei Nishikawa, Tomoharu Ohkawara, Kota Iwahori, Nobuyuki Ohguro, T Kishimoto, Tetsuji Naka
Publicado em 2009Artigo -
4
CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia Por Challice L. Bonifant, Árpád Szöőr, David Torres, Nicholos Joseph, Mireya Paulina Velasquez, Kota Iwahori, Amos Gaikwad, Phuong Nguyen, Caroline Arber, Xiao‐Tong Song, Michele S. Redell, Stephen Gottschalk
Publicado em 2016Artigo -
5
ICOS<sup>+</sup>Foxp3<sup>+</sup>TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with<i>H</i><i>elicobacter pylori</i> Por Hirotsugu Nagase, Tomohira Takeoka, Shinya Urakawa, Akiko Morimoto-Okazawa, Atsunari Kawashima, Kota Iwahori, Shuji Takiguchi, Hiroyoshi Nishikawa, Eiichi Sato, Shimon Sakaguchi, Masaki Mori, Yuichiro� Doki, Hisashi Wada
Publicado em 2016Artigo -
6
Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment Por Kota Iwahori, Yasushi Shintani, Soichiro Funaki, Yoko Yamamoto, Mitsunobu Matsumoto, Tetsuya Yoshida, Akiko Morimoto-Okazawa, Atsunari Kawashima, Eiichi Sato, Stephen Gottschalk, Meinoshin Okumura, Atsushi Kumanogoh, Hisashi Wada
Publicado em 2019Artigo -
7
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies Por Mireya Paulina Velasquez, David Torres, Kota Iwahori, Sunitha Kakarla, Caroline Arber, Tania Rodríguez-Cruz, Árpád Szöőr, Challice L. Bonifant, Claudia Gerken, Laurence J.N. Cooper, Xiao‐Tong Song, Stephen Gottschalk
Publicado em 2016Artigo -
8
Impact of sarcopenia in patients with advanced non–small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study Por Takayuki Shiroyama, Izumi Nagatomo, Shohei Koyama, Haruhiko Hirata, Sumiyuki Nishida, Kotaro Miyake, Kiyoharu Fukushima, Yuya Shirai, Yuichi Mitsui, So Takata, Kentaro Masuhiro, Moto Yaga, Kota Iwahori, Yoshito Takeda, Hiroshi Kida, Atsushi Kumanogoh
Publicado em 2019Artigo -
9
The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancer Por Miya Haruna, Azumi Ueyama, Yoko Yamamoto, Michinari Hirata, Kumiko Goto, Hiroshi Yoshida, Naoko Higuchi, Tetsuya Yoshida, Yujiro Kidani, Yamami Nakamura, Morio Nagira, Atsunari Kawashima, Kota Iwahori, Yasushi Shintani, Naganari Ohkura, Hisashi Wada
Publicado em 2022Artigo -
10
Identification of CD72 as a Lymphocyte Receptor for the Class IV Semaphorin CD100 Por Atsushi Kumanogoh, Chie Watanabe, Ihn-Sook Lee, Xiaosong Wang, Wei Shi, Hiroshi Araki, Haruhiko Hirata, Kota Iwahori, Junji Uchida, Teruhito Yasui, Makoto Matsumoto, Kenji Yoshida, Hidetaka Yakura, Chin Pan, Jane R. Parnes, Hitoshi Kikutani
Publicado em 2000Artigo -
11
Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging Por Yingji Jin, Yoshito Takeda, Yasushi Kondo, Lokesh P. Tripathi, Sujin Kang, Hikari Takeshita, Hanako Kuhara, Yohei Maeda, Masayoshi Higashiguchi, Kotaro Miyake, Osamu Morimura, Taro Koba, Yoshitomo Hayama, Shohei Koyama, Kaori Nakanishi, Takeo Iwasaki, Satoshi Tetsumoto, Kazuyuki Tsujino, Muneyoshi Kuroyama, Kota Iwahori, Haruhiko Hirata, Takayuki Takimoto, Mayumi Suzuki, Izumi Nagatomo, Ken Sugimoto, Yuta Fujii, Hiroshi Kida, Kenji Mizuguchi, Mari Ito, Takashi Kijima, Hiromi Rakugi, Eisuke Mekada, Isao Tachibana, Atsushi Kumanogoh
Publicado em 2018Artigo -
12
Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients Por Akio Osa, Takeshi Uenami, Shohei Koyama, Kosuke Fujimoto, Daisuke Okuzaki, Takayuki Takimoto, Haruhiko Hirata, Yukihiro Yano, Soichiro Yokota, Yuhei Kinehara, Yujiro Naito, Tomoyuki Otsuka, Masaki Kanazu, Muneyoshi Kuroyama, Masanari Hamaguchi, Taro Koba, Yu Futami, Mikako Ishijima, Yasuhiko Suga, Yuki Akazawa, Hirotomo Machiyama, Kota Iwahori, Hyota Takamatsu, Izumi Nagatomo, Yoshito Takeda, Hiroshi Kida, Esra A. Akbay, Peter S. Hammerman, Kwok‐Kin Wong, Glenn Dranoff, Masahide Mori, Takashi Kijima, Atsushi Kumanogoh
Publicado em 2018Artigo -
13
Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells Por Yuhei Kinehara, Izumi Nagatomo, Shohei Koyama, Daisuke Ito, Satoshi Nojima, Ryota Kurebayashi, Yoshimitsu Nakanishi, Yasuhiko Suga, Yu Nishijima-Futami, Akio Osa, Takeshi Nakatani, Yasuhiro Kato, Masayuki Nishide, Yoshitomo Hayama, Masayoshi Higashiguchi, Osamu Morimura, Kotaro Miyake, Sujin Kang, Toshiyuki Minami, Haruhiko Hirata, Kota Iwahori, Takayuki Takimoto, Hyota Takamatsu, Yoshito Takeda, Naoki Hosen, Shigenori Hoshino, Yasushi Shintani, Meinoshin Okumura, Toru Kumagai, Kazumi Nishino, Fumio Imamura, Shin‐ichi Nakatsuka, Takashi Kijima, Hiroshi Kida, Atsushi Kumanogoh
Publicado em 2018Artigo -
14
Galectin-10 in serum extracellular vesicles reflects asthma pathophysiology Por Hanako Yoshimura, Yoshito Takeda, Yuya Shirai, Makoto Yamamoto, Daisuke Nakatsubo, Saori Amiya, Takatoshi Enomoto, Reina Hara, Yuichi Adachi, Ryuya Edahiro, Moto Yaga, Kentaro Masuhiro, Taro Koba, Miho Itoh-Takahashi, Mana Nakayama, So Takata, Yuki Hosono, Sho Obata, Masayuki Nishide, Akinori Hata, Masahiro Yanagawa, Satoko Namba, M Iwata, Momoko Hamano, Haruhiko Hirata, Shohei Koyama, Kota Iwahori, Izumi Nagatomo, Yasuhiko Suga, Kotaro Miyake, Takayuki Shiroyama, Kiyoharu Fukushima, Shinji Futami, Yujiro Naito, Takahiro Kawasaki, Kenji Mizuguchi, Yusuke Kawashima, Yoshihiro Yamanishi, Jun Adachi, M Itoh, Shigeharu Ueki, Atsushi Kumanogoh
Publicado em 2024Artigo -
15
Tumor-derived semaphorin 4A improves PD-1–blocking antibody efficacy by enhancing CD8 <sup>+</sup> T cell cytotoxicity and proliferation Por Yujiro Naito, Shohei Koyama, Kentaro Masuhiro, Takashi Hirai, Takeshi Uenami, Takako Inoue, Akio Osa, Hirotomo Machiyama, Go Watanabe, Nicolas Sax, Jordan K. Villa, Yumi Kinugasa‐Katayama, Satoshi Nojima, Moto Yaga, Yuki Hosono, Daisuke Okuzaki, S. Satoh, Takeshi Tsuda, Yoshimitsu Nakanishi, Yasuhiko Suga, Takayoshi Morita, Kiyoharu Fukushima, Masayuki Nishide, Takayuki Shiroyama, Kotaro Miyake, Kota Iwahori, Haruhiko Hirata, Izumi Nagatomo, Yukihiro Yano, Motohiro Tamiya, Toru Kumagai, Norihiko Takemoto, Hidenori Inohara, Sho Yamasaki, Kazuo Yamashita, Taiki Aoshi, Esra A. Akbay, Naoki Hosen, Yasushi Shintani, Hyota Takamatsu, Masahide Mori, Yoshito Takeda, Atsushi Kumanogoh
Publicado em 2023Artigo
Ferramentas de pesquisa:
Assuntos relacionados
Immunology
Biology
Cancer research
Medicine
Biochemistry
Immune system
Immunotherapy
T cell
Internal medicine
Lung cancer
Cancer
In vitro
CD8
Cell biology
Cytotoxic T cell
Pathology
Antibody
Antigen
Cancer immunotherapy
Chemistry
Apoptosis
Cell
Computational biology
Cytotoxicity
Gene knockdown
Genetics
IL-2 receptor
Nivolumab
Oncology
Receptor